| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Oct 30, 2020 | Buy(P) | 5K | $24.03 | $120K | 150K |
| Oct 30, 2020 | Buy(P) | 31K | $24.53 | $760K | 181K |
| Oct 30, 2020 | Buy(P) | 4K | $25.97 | $104K | 185K |
| Oct 30, 2020 | Buy(P) | 15K | $26.48 | $397K | 200K |
| Oct 30, 2020 | Buy(P) | 9K | $25.55 | $232K | 224K |
| Oct 30, 2020 | Buy(P) | 13K | $25.88 | $335K | 200K |
| Oct 30, 2020 | Sell(S) | 27 | $27.02 | $730 | 200K |
| Oct 30, 2020 | Buy(P) | 15K | $26.17 | $393K | 215K |
| Oct 30, 2020 | Sell(S) | 13K | $26.64 | $345K | 187K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-20-018886) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Novus Therapeutics, Inc.
This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/filing/0001567619-20-018886"
Use Arkolith to summarize insider buying and selling at Novus Therapeutics, Inc. over the last 90 days and cite the filings.